|
BE615511A
(https=)
|
1961-03-25 |
|
|
|
|
NL292958A
(https=)
|
1962-05-29 |
1900-01-01 |
|
|
|
GB8809205D0
(en)
|
1988-04-19 |
1988-05-25 |
Nye P C G |
Treatment of oedema
|
|
US5137871A
(en)
|
1989-07-28 |
1992-08-11 |
Regents Of The University Of California |
Treatment to reduce edema for brain and musculature injuries
|
|
DE4010536A1
(de)
*
|
1990-04-02 |
1991-10-10 |
Boehringer Mannheim Gmbh |
Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure
|
|
US5486530A
(en)
|
1991-04-27 |
1996-01-23 |
Boehringer Mannheim Gmbh |
Use of torasemide for the treatment of brain oedemas
|
|
DE4113820A1
(de)
|
1991-04-27 |
1992-10-29 |
Boehringer Mannheim Gmbh |
Verwendung von torasemid zur behandlung von hirnoedemen
|
|
US5858702A
(en)
|
1991-12-13 |
1999-01-12 |
The Johns Hopkins University |
Isolation, cloning and expression of transmembrane water channel Aquaporin 5 (AQP5)
|
|
US5741671A
(en)
|
1991-12-12 |
1998-04-21 |
The Johns Hopkins University |
Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1)
|
|
US5519035A
(en)
|
1993-07-02 |
1996-05-21 |
Cornell Research Foundation, Inc. |
Treatment of stroke or in anticipation of the occurrence of brain ischemia
|
|
US20060167110A1
(en)
|
1995-01-13 |
2006-07-27 |
Blume Cherly D |
Methods for treating cerebrovascular disease by administering desmethylselegiline
|
|
WO1998021951A1
(en)
|
1996-11-18 |
1998-05-28 |
Emisphere Technologies, Inc. |
Methods and compositions for inducing oral tolerance in mammals
|
|
WO1999007382A1
(en)
|
1997-08-06 |
1999-02-18 |
Smithkline Beecham Corporation |
Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
|
|
US5905090A
(en)
|
1998-04-29 |
1999-05-18 |
Italfarmaco S.P.A. |
Analogues of the active metabolite of leflunomide
|
|
CO5180581A1
(es)
*
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
|
US6500809B1
(en)
|
1999-11-12 |
2002-12-31 |
Neuron Therapeutics, Inc. |
Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
|
|
DK1106614T3
(da)
|
1999-12-10 |
2004-04-13 |
Pfizer |
5-leddede, heteroarylsubstituerede 1,4-dihydropyridinforbindelser som bradykininantagonister
|
|
JP4224566B2
(ja)
|
2000-12-18 |
2009-02-18 |
株式会社医薬分子設計研究所 |
炎症性サイトカイン産生遊離抑制剤
|
|
US8980952B2
(en)
|
2002-03-20 |
2015-03-17 |
University Of Maryland, Baltimore |
Methods for treating brain swelling with a compound that blocks a non-selective cation channel
|
|
EP2438913B1
(en)
|
2002-03-20 |
2020-05-06 |
University of Maryland, Baltimore |
A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling
|
|
CN1658854A
(zh)
|
2002-06-05 |
2005-08-24 |
株式会社医药分子设计研究所 |
免疫关联蛋白激酶抑制剂
|
|
CN101103977A
(zh)
|
2002-06-05 |
2008-01-16 |
株式会社医药分子设计研究所 |
糖尿病治疗药
|
|
EP1512396A4
(en)
|
2002-06-05 |
2008-12-31 |
Inst Med Molecular Design Inc |
HEMMER AGAINST ACTIVATION OF AP-1 AND NFAT
|
|
CA2488363C
(en)
|
2002-06-06 |
2011-01-04 |
Institute Of Medicinal Molecular Design, Inc. |
O-substituted hydroxyaryl derivatives
|
|
EA009701B1
(ru)
|
2002-06-06 |
2008-02-28 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
Противоаллергические средства
|
|
EA010470B1
(ru)
|
2002-06-10 |
2008-08-29 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
ИНГИБИТОРЫ АКТИВАЦИИ NF-kB
|
|
EP1535610A4
(en)
|
2002-06-10 |
2008-12-31 |
Inst Med Molecular Design Inc |
THERAPEUTIC CANCER
|
|
US20060035944A1
(en)
|
2002-06-11 |
2006-02-16 |
Susumu Muto |
Remedies for neurodegenerative diseases
|
|
CN1681487A
(zh)
|
2002-07-15 |
2005-10-12 |
美瑞德生物工程公司 |
化合物、组合物及其使用方法
|
|
DK1590458T3
(da)
|
2003-02-06 |
2013-02-04 |
Univ Belfast |
Bradykinin B2-receptorantagonistpeptid fra amfibiehud
|
|
US20080125488A1
(en)
|
2003-05-01 |
2008-05-29 |
Leverve Xavier M |
Lactate Containing Pharmaceutical Composition and Uses Thereof
|
|
JPWO2005007151A1
(ja)
|
2003-07-16 |
2006-08-31 |
株式会社医薬分子設計研究所 |
皮膚色素沈着の治療剤
|
|
MXPA06004005A
(es)
|
2003-10-08 |
2006-06-28 |
Vertex Pharma |
Moduladores de transportadores con casete de union con atp.
|
|
US8467876B2
(en)
|
2003-10-15 |
2013-06-18 |
Rmx, Llc |
Breathing disorder detection and therapy delivery device and method
|
|
WO2005039556A1
(ja)
|
2003-10-29 |
2005-05-06 |
Institute Of Medicinal Molecular Design. Inc. |
血行再建術後の再狭窄又は再閉塞の治療及び／又は予防のための医薬
|
|
EP1691817A2
(en)
|
2003-12-02 |
2006-08-23 |
Corgentech, Inc. |
NF-kB OLIGONUCLEOTIDE DECOY MOLECULES
|
|
JP5085326B2
(ja)
|
2004-09-18 |
2012-11-28 |
ユニバーシティ オブ メリーランド，ボルチモア |
ＮＣＣａ−ＡＴＰチャネルを標的とする処置剤およびその使用方法
|
|
EP1802313B1
(en)
|
2004-09-18 |
2010-11-03 |
University of Maryland, Baltimore |
Therapeutic agents trageting the ncca-atp channel and methods of use thereof
|
|
US7601745B2
(en)
|
2004-09-27 |
2009-10-13 |
4Sc Ag |
Heterocyclic NF-kB inhibitors
|
|
KR20070111475A
(ko)
|
2005-01-04 |
2007-11-21 |
노파르티스 아게 |
만성 변비 환자에서 테가세로드의 효능을 확인하기 위한바이오마커
|
|
MY147790A
(en)
*
|
2005-04-28 |
2013-01-31 |
Takeda Pharmaceutical |
Stable emulsion composition
|
|
WO2007084464A2
(en)
|
2006-01-17 |
2007-07-26 |
The University Of North Carolina At Chapel Hill |
Water channel blockers and methods of use thereof
|
|
JP4273235B2
(ja)
*
|
2006-06-01 |
2009-06-03 |
国立大学法人 新潟大学 |
アクアポリン４阻害薬
|
|
NZ572177A
(en)
|
2006-06-06 |
2012-02-24 |
Genentech Inc |
Anti-dll4 antibodies and methods using same
|
|
EP2029159A2
(en)
|
2006-06-06 |
2009-03-04 |
Genentech, Inc. |
Compositions and methods for modulating vascular development
|
|
US7671058B2
(en)
|
2006-06-21 |
2010-03-02 |
Institute Of Medicinal Molecular Design, Inc. |
N-(3,4-disubstituted phenyl) salicylamide derivatives
|
|
US10004703B2
(en)
|
2006-10-12 |
2018-06-26 |
Biogen Chesapeake Llc |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels
|
|
WO2008046014A1
(en)
|
2006-10-12 |
2008-04-17 |
Remedy Pharmaceuticals, Inc. |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective ca++- activated atp-sensitive cation channels regulated by sur1 receptors
|
|
US7906555B2
(en)
|
2006-10-26 |
2011-03-15 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
|
WO2008067196A2
(en)
|
2006-11-16 |
2008-06-05 |
The Regents Of The University Of California |
Methods for identifying inhibitors of solute transporters
|
|
US20080171719A1
(en)
|
2006-11-28 |
2008-07-17 |
Alcon Manufacturing, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
WO2008067382A2
(en)
|
2006-11-28 |
2008-06-05 |
Alcon Research, Ltd. |
Rnai-mediated inhibition of aquaporin 4 for treatment of iop-related conditions
|
|
US9511075B2
(en)
|
2007-01-12 |
2016-12-06 |
The University Of Maryland, Baltimore |
Targeting NCCA-ATP channel for organ protection following ischemic episode
|
|
ES2660173T3
(es)
|
2007-01-16 |
2018-03-21 |
Ipintl, Llc |
Nueva composición para el tratamiento del síndrome metabólico
|
|
US20120183600A1
(en)
*
|
2007-01-16 |
2012-07-19 |
Chien-Hung Chen |
Novel composition for treating metabolic syndrome and other conditions
|
|
EP2114160B1
(en)
|
2007-02-09 |
2016-11-16 |
University of Maryland, Baltimore |
Antagonists of a non-selective cation channel in neural cells
|
|
EP2543249B1
(en)
|
2007-02-17 |
2018-05-23 |
President and Fellows of Harvard College |
Compositions and method for tissue preservation
|
|
TW200848063A
(en)
|
2007-04-23 |
2008-12-16 |
Combinatorx Inc |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
CA2691199C
(en)
|
2007-06-22 |
2017-09-12 |
Marc J. Simard |
Inhibitors of ncca-atp channels for therapy
|
|
WO2009006555A2
(en)
*
|
2007-07-02 |
2009-01-08 |
Yu, Ming |
Methods, composition, targets for combinational cancer treatments
|
|
WO2009054439A1
(ja)
|
2007-10-23 |
2009-04-30 |
Institute Of Medicinal Molecular Design, Inc. |
Pai-1産生抑制剤
|
|
US20090239868A1
(en)
|
2007-10-23 |
2009-09-24 |
Institute Of Medical Molecular Design, Inc. |
Inhibitor of pai-1 production
|
|
ES2638977T3
(es)
|
2007-12-04 |
2017-10-24 |
Biogen Chesapeake Llc |
Formulaciones y procedimientos mejorados para liofilización y liofilizados obtenidos por los mismos
|
|
GB0724340D0
(en)
|
2007-12-13 |
2008-01-30 |
Univ Dundee |
Novel Therapeutic Agents
|
|
WO2009086303A2
(en)
*
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US20110034560A1
(en)
|
2008-01-29 |
2011-02-10 |
Sven Jacobson |
Liquid formulations of compounds active at sulfonylurea receptors
|
|
US8211882B2
(en)
|
2008-03-08 |
2012-07-03 |
Richard Delarey Wood |
Glutamate receptor modulators and therapeutic agents
|
|
US20090286799A1
(en)
|
2008-05-16 |
2009-11-19 |
Zhi-Gang Jiang |
Methods for the treatment of brain edema
|
|
EP2719380A3
(en)
|
2008-09-16 |
2014-07-30 |
University of Maryland, Baltimore |
SUR1 inhibitors for therapy
|
|
US20120010178A1
(en)
|
2008-10-21 |
2012-01-12 |
President And Fellows Of Harvard College |
Methods and compounds for treatment of neurodegenerative disorders
|
|
GB0823366D0
(en)
|
2008-12-22 |
2009-01-28 |
Uni I Oslo |
Synthesis
|
|
CA2749575C
(en)
|
2009-01-12 |
2016-05-03 |
Versitech Limited |
Compounds and uses thereof for treating inflammation and modulating immune responses
|
|
WO2010096627A1
(en)
|
2009-02-20 |
2010-08-26 |
Lisanti Michael P |
Therapeutics and methods for treating neoplastic diseases comprising determining the level of caveolin-1 and/or caveolin-2 in a stromal cell sample
|
|
EP2544706B1
(en)
|
2010-03-10 |
2015-06-17 |
The University Of Melbourne |
Modulating aquaporins with relaxin
|
|
KR20190031592A
(ko)
|
2010-07-19 |
2019-03-26 |
바이오젠 체사피크 엘엘씨 |
글리부리드 및 다른 약물의 정맥내 투여를 위한 방법
|
|
JP2013535457A
(ja)
*
|
2010-07-28 |
2013-09-12 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器系及び炎症性疾患の治療用医薬組成物
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
WO2012125749A2
(en)
|
2011-03-14 |
2012-09-20 |
Io Therapeutics, Inc. |
INFLAMMATION AND AUTOIMMUNE DISORDER TREATMENT USING RARα SELECTIVE AGONISTS
|
|
HRP20170553T1
(hr)
|
2011-05-02 |
2017-06-02 |
Stichting Vumc |
Zaštita protiv disfunkcije endotelne barijere putem inhibicije gena povezanog s tirozin kinazom abl (arg)
|
|
RU2461375C1
(ru)
*
|
2011-05-19 |
2012-09-20 |
Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) |
Способ комбинированного лечения больных местно-распространенным раком желудка
|
|
WO2013152313A1
(en)
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
US9452973B2
(en)
|
2012-05-04 |
2016-09-27 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Modulators of the relaxin receptor 1
|
|
WO2013169939A2
(en)
*
|
2012-05-08 |
2013-11-14 |
Aeromics, Llc |
New methods
|
|
WO2015037659A1
(ja)
|
2013-09-13 |
2015-03-19 |
株式会社医薬分子設計研究所 |
水溶液製剤及びその製造方法
|
|
US20160279155A1
(en)
|
2013-11-06 |
2016-09-29 |
Aeromics, Inc. |
Novel formulations
|
|
CA2931550C
(en)
|
2013-12-13 |
2023-09-26 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of pyridone amides useful as modulators of sodium channels
|
|
AU2015346076A1
(en)
|
2014-11-13 |
2017-06-15 |
Aeromics, Inc. |
Novel methods
|
|
US10900040B2
(en)
|
2015-05-29 |
2021-01-26 |
University Of Maryland, Baltimore |
Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells
|
|
WO2017062765A1
(en)
|
2015-10-07 |
2017-04-13 |
Remedy Pharmaceuticals, Inc. |
Methods of treating injuries or conditions related to cns edema
|
|
US11117909B2
(en)
|
2016-05-13 |
2021-09-14 |
Aeromics, Inc. |
Crystals
|
|
CN109689037B
(zh)
|
2016-07-29 |
2022-09-13 |
生物切萨皮克有限责任公司 |
利用sur1-trpm4通道抑制剂的医学治疗方法
|
|
EP4192442A4
(en)
*
|
2020-08-05 |
2025-03-19 |
Jiangsu Simcere Pharmaceutical Co., Ltd. |
Pharmaceutical composition comprising an aquaporin inhibiter and manufacturing process therefor
|